Rubedo Life Sciences, Inc. (Rubedo), an AI-driven, clinical-stage biotech focused on discovering and rapidly developing ...

Cocrystals of approved APIs should go through approval process for new drugs: CDSCO: Gireesh Babu, New Delhi Wednesday, September 17, 2025, 08:00 Hrs [IST] The Central Drugs Stand ...

The Central Drugs Standard Control Organization (CDSCO), under the Directorate General of Health Services, has issued a ...

Mosaic becomes the exclusive provider of antibody discovery services using AbTherx's Atlas™ Full Human Diversity MouseStreamlined milestone- and royalty-free access with flexible engagement optionsEnd ...

Mosaic becomes the exclusive provider of antibody discovery services using AbTherx's Atlas Full Human Diversity MouseStreamlined milestone- and royalty-free access with flexible engagement optionsEnd- ...

(GLOBE NEWSWIRE) -- (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that an ...

TransMedics' growth is set to remain robust over the next 12 months, supported by its heart and lung clinical trials. Click ...

EVERLAST-A Phase 2a trial enrollment ongoing with data expected 2H 2026 MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) - ...

Half-life of approximately 100 days increases likelihood of once-per-year dosing Pharmacokinetic profile supports the ability to achieve exposures that could lead to higher efficacy and extended off-t ...